nodes	percent_of_prediction	percent_of_DWPC	metapath
Formoterol—ADRB2—Levobunolol—glaucoma	0.0797	0.101	CbGbCtD
Formoterol—ADRB2—Metipranolol—glaucoma	0.0797	0.101	CbGbCtD
Formoterol—ADRB1—Metipranolol—glaucoma	0.0785	0.099	CbGbCtD
Formoterol—ADRB1—Levobunolol—glaucoma	0.0785	0.099	CbGbCtD
Formoterol—ADRB2—Carteolol—glaucoma	0.0678	0.0855	CbGbCtD
Formoterol—ADRB1—Carteolol—glaucoma	0.0668	0.0842	CbGbCtD
Formoterol—ADRB2—Dipivefrin—glaucoma	0.0483	0.0609	CbGbCtD
Formoterol—ADRB2—Betaxolol—glaucoma	0.0458	0.0577	CbGbCtD
Formoterol—ADRB1—Betaxolol—glaucoma	0.0451	0.0569	CbGbCtD
Formoterol—CYP2A6—Pilocarpine—glaucoma	0.041	0.0517	CbGbCtD
Formoterol—ADRB2—Timolol—glaucoma	0.0295	0.0372	CbGbCtD
Formoterol—ADRB1—Timolol—glaucoma	0.0291	0.0366	CbGbCtD
Formoterol—CYP2D6—Carteolol—glaucoma	0.017	0.0214	CbGbCtD
Formoterol—CYP2D6—Betaxolol—glaucoma	0.0115	0.0145	CbGbCtD
Formoterol—CYP2C19—Methazolamide—glaucoma	0.0115	0.0144	CbGbCtD
Formoterol—CYP2C9—Diclofenamide—glaucoma	0.0111	0.0139	CbGbCtD
Formoterol—CYP2C9—Dorzolamide—glaucoma	0.0107	0.0135	CbGbCtD
Formoterol—CYP2C19—Timolol—glaucoma	0.00974	0.0123	CbGbCtD
Formoterol—CYP2C9—Methazolamide—glaucoma	0.00952	0.012	CbGbCtD
Formoterol—CYP2D6—Methazolamide—glaucoma	0.00871	0.011	CbGbCtD
Formoterol—CYP2D6—Timolol—glaucoma	0.0074	0.00933	CbGbCtD
Formoterol—CYP2D6—Clonidine—glaucoma	0.00629	0.00793	CbGbCtD
Formoterol—Dobutamine—CA5A—glaucoma	0.00265	0.71	CrCbGaD
Formoterol—ADRB2—Treprostinil—Latanoprost—glaucoma	0.00224	1	CbGdCrCtD
Formoterol—Dobutamine—CA2—glaucoma	0.00108	0.29	CrCbGaD
Formoterol—Asthenia—Apraclonidine—glaucoma	0.000124	0.000621	CcSEcCtD
Formoterol—Somnolence—Brinzolamide—glaucoma	0.000124	0.00062	CcSEcCtD
Formoterol—Urticaria—Acetazolamide—glaucoma	0.000123	0.000615	CcSEcCtD
Formoterol—Tremor—Clonidine—glaucoma	0.000123	0.000615	CcSEcCtD
Formoterol—Dyspepsia—Brinzolamide—glaucoma	0.000122	0.000614	CcSEcCtD
Formoterol—Pruritus—Apraclonidine—glaucoma	0.000122	0.000612	CcSEcCtD
Formoterol—Body temperature increased—Acetazolamide—glaucoma	0.000122	0.000612	CcSEcCtD
Formoterol—Fatigue—Dorzolamide—glaucoma	0.000122	0.000612	CcSEcCtD
Formoterol—Musculoskeletal discomfort—Pilocarpine—glaucoma	0.000122	0.000611	CcSEcCtD
Formoterol—Gastrointestinal disorder—Travoprost—glaucoma	0.000122	0.00061	CcSEcCtD
Formoterol—Fatigue—Travoprost—glaucoma	0.000122	0.000609	CcSEcCtD
Formoterol—Cardiac disorder—Betaxolol—glaucoma	0.000121	0.000609	CcSEcCtD
Formoterol—Ill-defined disorder—Clonidine—glaucoma	0.000121	0.000609	CcSEcCtD
Formoterol—Pain—Dorzolamide—glaucoma	0.000121	0.000607	CcSEcCtD
Formoterol—Insomnia—Pilocarpine—glaucoma	0.000121	0.000606	CcSEcCtD
Formoterol—Pain—Travoprost—glaucoma	0.000121	0.000604	CcSEcCtD
Formoterol—Constipation—Travoprost—glaucoma	0.000121	0.000604	CcSEcCtD
Formoterol—Hyperglycaemia—Timolol—glaucoma	0.000121	0.000604	CcSEcCtD
Formoterol—Agitation—Clonidine—glaucoma	0.00012	0.000603	CcSEcCtD
Formoterol—Gastrointestinal disorder—Brinzolamide—glaucoma	0.00012	0.000602	CcSEcCtD
Formoterol—Asthenia—Bimatoprost—glaucoma	0.00012	0.000602	CcSEcCtD
Formoterol—Fatigue—Brinzolamide—glaucoma	0.00012	0.000601	CcSEcCtD
Formoterol—Angioedema—Clonidine—glaucoma	0.00012	0.000599	CcSEcCtD
Formoterol—Dyspnoea—Pilocarpine—glaucoma	0.000119	0.000598	CcSEcCtD
Formoterol—Pain—Brinzolamide—glaucoma	0.000119	0.000596	CcSEcCtD
Formoterol—Somnolence—Pilocarpine—glaucoma	0.000119	0.000596	CcSEcCtD
Formoterol—Pruritus—Bimatoprost—glaucoma	0.000118	0.000593	CcSEcCtD
Formoterol—Immune system disorder—Betaxolol—glaucoma	0.000118	0.000592	CcSEcCtD
Formoterol—Diarrhoea—Apraclonidine—glaucoma	0.000118	0.000592	CcSEcCtD
Formoterol—Malaise—Clonidine—glaucoma	0.000118	0.000591	CcSEcCtD
Formoterol—Mediastinal disorder—Betaxolol—glaucoma	0.000118	0.000591	CcSEcCtD
Formoterol—Dyspepsia—Pilocarpine—glaucoma	0.000118	0.00059	CcSEcCtD
Formoterol—Arrhythmia—Betaxolol—glaucoma	0.000117	0.000586	CcSEcCtD
Formoterol—Feeling abnormal—Dorzolamide—glaucoma	0.000117	0.000585	CcSEcCtD
Formoterol—Feeling abnormal—Travoprost—glaucoma	0.000116	0.000582	CcSEcCtD
Formoterol—Conjunctivitis—Timolol—glaucoma	0.000116	0.00058	CcSEcCtD
Formoterol—Gastrointestinal pain—Dorzolamide—glaucoma	0.000116	0.00058	CcSEcCtD
Formoterol—Palpitations—Clonidine—glaucoma	0.000116	0.00058	CcSEcCtD
Formoterol—Gastrointestinal disorder—Pilocarpine—glaucoma	0.000115	0.000579	CcSEcCtD
Formoterol—Gastrointestinal pain—Travoprost—glaucoma	0.000115	0.000578	CcSEcCtD
Formoterol—Feeling abnormal—Brinzolamide—glaucoma	0.000115	0.000575	CcSEcCtD
Formoterol—Mental disorder—Betaxolol—glaucoma	0.000115	0.000575	CcSEcCtD
Formoterol—Pain—Pilocarpine—glaucoma	0.000114	0.000573	CcSEcCtD
Formoterol—Constipation—Pilocarpine—glaucoma	0.000114	0.000573	CcSEcCtD
Formoterol—Cough—Clonidine—glaucoma	0.000114	0.000572	CcSEcCtD
Formoterol—Dizziness—Apraclonidine—glaucoma	0.000114	0.000572	CcSEcCtD
Formoterol—Malnutrition—Betaxolol—glaucoma	0.000114	0.000571	CcSEcCtD
Formoterol—Urticaria—Dorzolamide—glaucoma	0.000112	0.000564	CcSEcCtD
Formoterol—Abdominal pain—Dorzolamide—glaucoma	0.000112	0.000561	CcSEcCtD
Formoterol—Body temperature increased—Dorzolamide—glaucoma	0.000112	0.000561	CcSEcCtD
Formoterol—Tension—Betaxolol—glaucoma	0.000112	0.00056	CcSEcCtD
Formoterol—Sinusitis—Timolol—glaucoma	0.000112	0.00056	CcSEcCtD
Formoterol—Dysgeusia—Betaxolol—glaucoma	0.000112	0.000559	CcSEcCtD
Formoterol—Chest pain—Clonidine—glaucoma	0.000111	0.000558	CcSEcCtD
Formoterol—Arthralgia—Clonidine—glaucoma	0.000111	0.000558	CcSEcCtD
Formoterol—Abdominal pain—Travoprost—glaucoma	0.000111	0.000558	CcSEcCtD
Formoterol—Anxiety—Clonidine—glaucoma	0.000111	0.000556	CcSEcCtD
Formoterol—Asthenia—Acetazolamide—glaucoma	0.000111	0.000555	CcSEcCtD
Formoterol—Dizziness—Bimatoprost—glaucoma	0.000111	0.000555	CcSEcCtD
Formoterol—Nervousness—Betaxolol—glaucoma	0.000111	0.000555	CcSEcCtD
Formoterol—Unspecified disorder of skin and subcutaneous tissue—Clonidine—glaucoma	0.000111	0.000555	CcSEcCtD
Formoterol—Urticaria—Brinzolamide—glaucoma	0.000111	0.000554	CcSEcCtD
Formoterol—Feeling abnormal—Pilocarpine—glaucoma	0.00011	0.000552	CcSEcCtD
Formoterol—Discomfort—Clonidine—glaucoma	0.00011	0.000552	CcSEcCtD
Formoterol—Vomiting—Apraclonidine—glaucoma	0.00011	0.00055	CcSEcCtD
Formoterol—Muscle spasms—Betaxolol—glaucoma	0.00011	0.000549	CcSEcCtD
Formoterol—Gastrointestinal pain—Pilocarpine—glaucoma	0.000109	0.000548	CcSEcCtD
Formoterol—Hypersensitivity—Brimonidine—glaucoma	0.000109	0.000547	CcSEcCtD
Formoterol—Dry mouth—Clonidine—glaucoma	0.000109	0.000546	CcSEcCtD
Formoterol—Dermatitis—Apraclonidine—glaucoma	0.000109	0.000545	CcSEcCtD
Formoterol—Headache—Apraclonidine—glaucoma	0.000108	0.000542	CcSEcCtD
Formoterol—Rhinitis—Timolol—glaucoma	0.000107	0.000537	CcSEcCtD
Formoterol—Oedema—Clonidine—glaucoma	0.000107	0.000535	CcSEcCtD
Formoterol—Tremor—Betaxolol—glaucoma	0.000107	0.000535	CcSEcCtD
Formoterol—Asthenia—Brimonidine—glaucoma	0.000106	0.000533	CcSEcCtD
Formoterol—Infection—Clonidine—glaucoma	0.000106	0.000532	CcSEcCtD
Formoterol—Body temperature increased—Pilocarpine—glaucoma	0.000106	0.00053	CcSEcCtD
Formoterol—Abdominal pain—Pilocarpine—glaucoma	0.000106	0.00053	CcSEcCtD
Formoterol—Ill-defined disorder—Betaxolol—glaucoma	0.000106	0.00053	CcSEcCtD
Formoterol—Diarrhoea—Acetazolamide—glaucoma	0.000106	0.00053	CcSEcCtD
Formoterol—Rash—Bimatoprost—glaucoma	0.000106	0.000529	CcSEcCtD
Formoterol—Dermatitis—Bimatoprost—glaucoma	0.000105	0.000528	CcSEcCtD
Formoterol—Oedema peripheral—Timolol—glaucoma	0.000105	0.000528	CcSEcCtD
Formoterol—Connective tissue disorder—Timolol—glaucoma	0.000105	0.000527	CcSEcCtD
Formoterol—Pruritus—Brimonidine—glaucoma	0.000105	0.000526	CcSEcCtD
Formoterol—Headache—Bimatoprost—glaucoma	0.000105	0.000526	CcSEcCtD
Formoterol—Nervous system disorder—Clonidine—glaucoma	0.000105	0.000525	CcSEcCtD
Formoterol—Hypersensitivity—Dorzolamide—glaucoma	0.000104	0.000523	CcSEcCtD
Formoterol—Tachycardia—Clonidine—glaucoma	0.000104	0.000522	CcSEcCtD
Formoterol—Hypersensitivity—Travoprost—glaucoma	0.000104	0.00052	CcSEcCtD
Formoterol—Skin disorder—Clonidine—glaucoma	0.000104	0.00052	CcSEcCtD
Formoterol—Visual impairment—Timolol—glaucoma	0.000103	0.000516	CcSEcCtD
Formoterol—Malaise—Betaxolol—glaucoma	0.000103	0.000515	CcSEcCtD
Formoterol—Nausea—Apraclonidine—glaucoma	0.000103	0.000514	CcSEcCtD
Formoterol—Hypersensitivity—Brinzolamide—glaucoma	0.000103	0.000514	CcSEcCtD
Formoterol—Dizziness—Acetazolamide—glaucoma	0.000102	0.000512	CcSEcCtD
Formoterol—Asthenia—Dorzolamide—glaucoma	0.000102	0.000509	CcSEcCtD
Formoterol—Asthenia—Travoprost—glaucoma	0.000101	0.000507	CcSEcCtD
Formoterol—Palpitations—Betaxolol—glaucoma	0.000101	0.000505	CcSEcCtD
Formoterol—Pruritus—Dorzolamide—glaucoma	0.0001	0.000502	CcSEcCtD
Formoterol—Asthenia—Brinzolamide—glaucoma	9.98e-05	0.0005	CcSEcCtD
Formoterol—Hypotension—Clonidine—glaucoma	9.98e-05	0.0005	CcSEcCtD
Formoterol—Pruritus—Travoprost—glaucoma	9.97e-05	0.0005	CcSEcCtD
Formoterol—Cough—Betaxolol—glaucoma	9.94e-05	0.000498	CcSEcCtD
Formoterol—Nausea—Bimatoprost—glaucoma	9.94e-05	0.000498	CcSEcCtD
Formoterol—Cardiac disorder—Timolol—glaucoma	9.92e-05	0.000497	CcSEcCtD
Formoterol—Hypersensitivity—Pilocarpine—glaucoma	9.85e-05	0.000494	CcSEcCtD
Formoterol—Pruritus—Brinzolamide—glaucoma	9.85e-05	0.000493	CcSEcCtD
Formoterol—Vomiting—Acetazolamide—glaucoma	9.82e-05	0.000492	CcSEcCtD
Formoterol—Dizziness—Brimonidine—glaucoma	9.8e-05	0.000491	CcSEcCtD
Formoterol—Musculoskeletal discomfort—Clonidine—glaucoma	9.73e-05	0.000488	CcSEcCtD
Formoterol—Chest pain—Betaxolol—glaucoma	9.7e-05	0.000486	CcSEcCtD
Formoterol—Arthralgia—Betaxolol—glaucoma	9.7e-05	0.000486	CcSEcCtD
Formoterol—Myalgia—Betaxolol—glaucoma	9.7e-05	0.000486	CcSEcCtD
Formoterol—Diarrhoea—Dorzolamide—glaucoma	9.68e-05	0.000485	CcSEcCtD
Formoterol—Headache—Acetazolamide—glaucoma	9.67e-05	0.000485	CcSEcCtD
Formoterol—Anxiety—Betaxolol—glaucoma	9.67e-05	0.000484	CcSEcCtD
Formoterol—Insomnia—Clonidine—glaucoma	9.66e-05	0.000484	CcSEcCtD
Formoterol—Immune system disorder—Timolol—glaucoma	9.66e-05	0.000484	CcSEcCtD
Formoterol—Diarrhoea—Travoprost—glaucoma	9.64e-05	0.000483	CcSEcCtD
Formoterol—Mediastinal disorder—Timolol—glaucoma	9.64e-05	0.000483	CcSEcCtD
Formoterol—Unspecified disorder of skin and subcutaneous tissue—Betaxolol—glaucoma	9.63e-05	0.000483	CcSEcCtD
Formoterol—Asthenia—Pilocarpine—glaucoma	9.6e-05	0.000481	CcSEcCtD
Formoterol—Discomfort—Betaxolol—glaucoma	9.58e-05	0.00048	CcSEcCtD
Formoterol—Arrhythmia—Timolol—glaucoma	9.55e-05	0.000479	CcSEcCtD
Formoterol—Dyspnoea—Clonidine—glaucoma	9.52e-05	0.000477	CcSEcCtD
Formoterol—Diarrhoea—Brinzolamide—glaucoma	9.52e-05	0.000477	CcSEcCtD
Formoterol—Somnolence—Clonidine—glaucoma	9.5e-05	0.000476	CcSEcCtD
Formoterol—Dry mouth—Betaxolol—glaucoma	9.49e-05	0.000475	CcSEcCtD
Formoterol—Pruritus—Pilocarpine—glaucoma	9.46e-05	0.000474	CcSEcCtD
Formoterol—Mental disorder—Timolol—glaucoma	9.37e-05	0.000469	CcSEcCtD
Formoterol—Dizziness—Dorzolamide—glaucoma	9.36e-05	0.000469	CcSEcCtD
Formoterol—Rash—Brimonidine—glaucoma	9.35e-05	0.000468	CcSEcCtD
Formoterol—Dermatitis—Brimonidine—glaucoma	9.34e-05	0.000468	CcSEcCtD
Formoterol—Dizziness—Travoprost—glaucoma	9.32e-05	0.000467	CcSEcCtD
Formoterol—Malnutrition—Timolol—glaucoma	9.31e-05	0.000466	CcSEcCtD
Formoterol—Oedema—Betaxolol—glaucoma	9.3e-05	0.000466	CcSEcCtD
Formoterol—Headache—Brimonidine—glaucoma	9.29e-05	0.000465	CcSEcCtD
Formoterol—Infection—Betaxolol—glaucoma	9.24e-05	0.000463	CcSEcCtD
Formoterol—Gastrointestinal disorder—Clonidine—glaucoma	9.22e-05	0.000462	CcSEcCtD
Formoterol—Fatigue—Clonidine—glaucoma	9.21e-05	0.000462	CcSEcCtD
Formoterol—Dizziness—Brinzolamide—glaucoma	9.2e-05	0.000461	CcSEcCtD
Formoterol—Nausea—Acetazolamide—glaucoma	9.17e-05	0.00046	CcSEcCtD
Formoterol—Diarrhoea—Pilocarpine—glaucoma	9.15e-05	0.000459	CcSEcCtD
Formoterol—Tension—Timolol—glaucoma	9.13e-05	0.000458	CcSEcCtD
Formoterol—Pain—Clonidine—glaucoma	9.13e-05	0.000458	CcSEcCtD
Formoterol—Constipation—Clonidine—glaucoma	9.13e-05	0.000458	CcSEcCtD
Formoterol—Nervous system disorder—Betaxolol—glaucoma	9.12e-05	0.000457	CcSEcCtD
Formoterol—Dysgeusia—Timolol—glaucoma	9.12e-05	0.000457	CcSEcCtD
Formoterol—Tachycardia—Betaxolol—glaucoma	9.08e-05	0.000455	CcSEcCtD
Formoterol—Nervousness—Timolol—glaucoma	9.04e-05	0.000453	CcSEcCtD
Formoterol—Skin disorder—Betaxolol—glaucoma	9.03e-05	0.000453	CcSEcCtD
Formoterol—Vomiting—Dorzolamide—glaucoma	9e-05	0.000451	CcSEcCtD
Formoterol—Rash—Dorzolamide—glaucoma	8.92e-05	0.000447	CcSEcCtD
Formoterol—Dermatitis—Dorzolamide—glaucoma	8.92e-05	0.000447	CcSEcCtD
Formoterol—Rash—Travoprost—glaucoma	8.89e-05	0.000445	CcSEcCtD
Formoterol—Dermatitis—Travoprost—glaucoma	8.88e-05	0.000445	CcSEcCtD
Formoterol—Headache—Dorzolamide—glaucoma	8.87e-05	0.000444	CcSEcCtD
Formoterol—Vomiting—Brinzolamide—glaucoma	8.85e-05	0.000443	CcSEcCtD
Formoterol—Dizziness—Pilocarpine—glaucoma	8.84e-05	0.000443	CcSEcCtD
Formoterol—Headache—Travoprost—glaucoma	8.83e-05	0.000442	CcSEcCtD
Formoterol—Nausea—Brimonidine—glaucoma	8.8e-05	0.000441	CcSEcCtD
Formoterol—Feeling abnormal—Clonidine—glaucoma	8.8e-05	0.000441	CcSEcCtD
Formoterol—Rash—Brinzolamide—glaucoma	8.77e-05	0.00044	CcSEcCtD
Formoterol—Dermatitis—Brinzolamide—glaucoma	8.77e-05	0.000439	CcSEcCtD
Formoterol—Gastrointestinal pain—Clonidine—glaucoma	8.73e-05	0.000438	CcSEcCtD
Formoterol—Headache—Brinzolamide—glaucoma	8.72e-05	0.000437	CcSEcCtD
Formoterol—Hypotension—Betaxolol—glaucoma	8.69e-05	0.000435	CcSEcCtD
Formoterol—Angioedema—Timolol—glaucoma	8.51e-05	0.000426	CcSEcCtD
Formoterol—Vomiting—Pilocarpine—glaucoma	8.5e-05	0.000426	CcSEcCtD
Formoterol—Urticaria—Clonidine—glaucoma	8.49e-05	0.000425	CcSEcCtD
Formoterol—Musculoskeletal discomfort—Betaxolol—glaucoma	8.47e-05	0.000425	CcSEcCtD
Formoterol—Abdominal pain—Clonidine—glaucoma	8.44e-05	0.000423	CcSEcCtD
Formoterol—Body temperature increased—Clonidine—glaucoma	8.44e-05	0.000423	CcSEcCtD
Formoterol—Rash—Pilocarpine—glaucoma	8.43e-05	0.000423	CcSEcCtD
Formoterol—Dermatitis—Pilocarpine—glaucoma	8.43e-05	0.000422	CcSEcCtD
Formoterol—Insomnia—Betaxolol—glaucoma	8.41e-05	0.000422	CcSEcCtD
Formoterol—Nausea—Dorzolamide—glaucoma	8.41e-05	0.000421	CcSEcCtD
Formoterol—Headache—Pilocarpine—glaucoma	8.38e-05	0.00042	CcSEcCtD
Formoterol—Nausea—Travoprost—glaucoma	8.37e-05	0.00042	CcSEcCtD
Formoterol—Dyspnoea—Betaxolol—glaucoma	8.29e-05	0.000415	CcSEcCtD
Formoterol—Nausea—Brinzolamide—glaucoma	8.27e-05	0.000414	CcSEcCtD
Formoterol—Palpitations—Timolol—glaucoma	8.23e-05	0.000412	CcSEcCtD
Formoterol—Dyspepsia—Betaxolol—glaucoma	8.19e-05	0.00041	CcSEcCtD
Formoterol—Cough—Timolol—glaucoma	8.12e-05	0.000407	CcSEcCtD
Formoterol—Hypertension—Timolol—glaucoma	8.04e-05	0.000403	CcSEcCtD
Formoterol—Gastrointestinal disorder—Betaxolol—glaucoma	8.03e-05	0.000402	CcSEcCtD
Formoterol—Fatigue—Betaxolol—glaucoma	8.02e-05	0.000402	CcSEcCtD
Formoterol—Constipation—Betaxolol—glaucoma	7.95e-05	0.000399	CcSEcCtD
Formoterol—Pain—Betaxolol—glaucoma	7.95e-05	0.000399	CcSEcCtD
Formoterol—Nausea—Pilocarpine—glaucoma	7.94e-05	0.000398	CcSEcCtD
Formoterol—Chest pain—Timolol—glaucoma	7.92e-05	0.000397	CcSEcCtD
Formoterol—Myalgia—Timolol—glaucoma	7.92e-05	0.000397	CcSEcCtD
Formoterol—Arthralgia—Timolol—glaucoma	7.92e-05	0.000397	CcSEcCtD
Formoterol—Anxiety—Timolol—glaucoma	7.9e-05	0.000396	CcSEcCtD
Formoterol—Unspecified disorder of skin and subcutaneous tissue—Timolol—glaucoma	7.87e-05	0.000394	CcSEcCtD
Formoterol—Hypersensitivity—Clonidine—glaucoma	7.87e-05	0.000394	CcSEcCtD
Formoterol—Discomfort—Timolol—glaucoma	7.83e-05	0.000392	CcSEcCtD
Formoterol—Dry mouth—Timolol—glaucoma	7.75e-05	0.000388	CcSEcCtD
Formoterol—Asthenia—Clonidine—glaucoma	7.66e-05	0.000384	CcSEcCtD
Formoterol—Feeling abnormal—Betaxolol—glaucoma	7.66e-05	0.000384	CcSEcCtD
Formoterol—Oedema—Timolol—glaucoma	7.6e-05	0.000381	CcSEcCtD
Formoterol—Anaphylactic shock—Timolol—glaucoma	7.6e-05	0.000381	CcSEcCtD
Formoterol—Pruritus—Clonidine—glaucoma	7.56e-05	0.000379	CcSEcCtD
Formoterol—Infection—Timolol—glaucoma	7.55e-05	0.000378	CcSEcCtD
Formoterol—Nervous system disorder—Timolol—glaucoma	7.45e-05	0.000373	CcSEcCtD
Formoterol—Urticaria—Betaxolol—glaucoma	7.39e-05	0.00037	CcSEcCtD
Formoterol—Skin disorder—Timolol—glaucoma	7.38e-05	0.00037	CcSEcCtD
Formoterol—Body temperature increased—Betaxolol—glaucoma	7.35e-05	0.000368	CcSEcCtD
Formoterol—Diarrhoea—Clonidine—glaucoma	7.31e-05	0.000366	CcSEcCtD
Formoterol—Hypotension—Timolol—glaucoma	7.1e-05	0.000356	CcSEcCtD
Formoterol—Dizziness—Clonidine—glaucoma	7.06e-05	0.000354	CcSEcCtD
Formoterol—Musculoskeletal discomfort—Timolol—glaucoma	6.92e-05	0.000347	CcSEcCtD
Formoterol—Insomnia—Timolol—glaucoma	6.87e-05	0.000344	CcSEcCtD
Formoterol—Hypersensitivity—Betaxolol—glaucoma	6.85e-05	0.000343	CcSEcCtD
Formoterol—Vomiting—Clonidine—glaucoma	6.79e-05	0.00034	CcSEcCtD
Formoterol—Dyspnoea—Timolol—glaucoma	6.77e-05	0.000339	CcSEcCtD
Formoterol—Somnolence—Timolol—glaucoma	6.75e-05	0.000338	CcSEcCtD
Formoterol—Rash—Clonidine—glaucoma	6.73e-05	0.000338	CcSEcCtD
Formoterol—Dermatitis—Clonidine—glaucoma	6.73e-05	0.000337	CcSEcCtD
Formoterol—Headache—Clonidine—glaucoma	6.69e-05	0.000335	CcSEcCtD
Formoterol—Dyspepsia—Timolol—glaucoma	6.69e-05	0.000335	CcSEcCtD
Formoterol—Asthenia—Betaxolol—glaucoma	6.67e-05	0.000334	CcSEcCtD
Formoterol—Pruritus—Betaxolol—glaucoma	6.58e-05	0.00033	CcSEcCtD
Formoterol—Gastrointestinal disorder—Timolol—glaucoma	6.56e-05	0.000329	CcSEcCtD
Formoterol—Fatigue—Timolol—glaucoma	6.55e-05	0.000328	CcSEcCtD
Formoterol—Pain—Timolol—glaucoma	6.5e-05	0.000326	CcSEcCtD
Formoterol—Diarrhoea—Betaxolol—glaucoma	6.36e-05	0.000319	CcSEcCtD
Formoterol—Nausea—Clonidine—glaucoma	6.34e-05	0.000318	CcSEcCtD
Formoterol—Feeling abnormal—Timolol—glaucoma	6.26e-05	0.000314	CcSEcCtD
Formoterol—Gastrointestinal pain—Timolol—glaucoma	6.21e-05	0.000311	CcSEcCtD
Formoterol—Dizziness—Betaxolol—glaucoma	6.15e-05	0.000308	CcSEcCtD
Formoterol—Urticaria—Timolol—glaucoma	6.03e-05	0.000302	CcSEcCtD
Formoterol—Abdominal pain—Timolol—glaucoma	6.01e-05	0.000301	CcSEcCtD
Formoterol—Body temperature increased—Timolol—glaucoma	6.01e-05	0.000301	CcSEcCtD
Formoterol—Vomiting—Betaxolol—glaucoma	5.91e-05	0.000296	CcSEcCtD
Formoterol—Rash—Betaxolol—glaucoma	5.86e-05	0.000294	CcSEcCtD
Formoterol—Dermatitis—Betaxolol—glaucoma	5.86e-05	0.000294	CcSEcCtD
Formoterol—Headache—Betaxolol—glaucoma	5.83e-05	0.000292	CcSEcCtD
Formoterol—Hypersensitivity—Timolol—glaucoma	5.6e-05	0.00028	CcSEcCtD
Formoterol—Nausea—Betaxolol—glaucoma	5.52e-05	0.000277	CcSEcCtD
Formoterol—Asthenia—Timolol—glaucoma	5.45e-05	0.000273	CcSEcCtD
Formoterol—Pruritus—Timolol—glaucoma	5.37e-05	0.000269	CcSEcCtD
Formoterol—Diarrhoea—Timolol—glaucoma	5.2e-05	0.00026	CcSEcCtD
Formoterol—Dizziness—Timolol—glaucoma	5.02e-05	0.000252	CcSEcCtD
Formoterol—ADRB1—Endothelin Pathways—MYLK—glaucoma	4.9e-05	0.0418	CbGpPWpGaD
Formoterol—Vomiting—Timolol—glaucoma	4.83e-05	0.000242	CcSEcCtD
Formoterol—Rash—Timolol—glaucoma	4.79e-05	0.00024	CcSEcCtD
Formoterol—Dermatitis—Timolol—glaucoma	4.79e-05	0.00024	CcSEcCtD
Formoterol—Headache—Timolol—glaucoma	4.76e-05	0.000239	CcSEcCtD
Formoterol—Nausea—Timolol—glaucoma	4.51e-05	0.000226	CcSEcCtD
Formoterol—CYP2C19—Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)—CYP1B1—glaucoma	4.04e-05	0.0344	CbGpPWpGaD
Formoterol—CYP2C9—Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)—CYP1B1—glaucoma	3.68e-05	0.0314	CbGpPWpGaD
Formoterol—CYP2C19—Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)—CYP1B1—glaucoma	3.67e-05	0.0313	CbGpPWpGaD
Formoterol—CYP2C9—Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)—CYP1B1—glaucoma	3.35e-05	0.0286	CbGpPWpGaD
Formoterol—CYP2A6—Tamoxifen metabolism—CYP1B1—glaucoma	3.06e-05	0.0261	CbGpPWpGaD
Formoterol—ADRB1—Melatonin metabolism and effects—CYP1B1—glaucoma	2.71e-05	0.0231	CbGpPWpGaD
Formoterol—CYP2A6—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—MMP1—glaucoma	2.59e-05	0.022	CbGpPWpGaD
Formoterol—ADRB2—GPCRs, Other—PTGFR—glaucoma	2.58e-05	0.022	CbGpPWpGaD
Formoterol—ADRB1—Melatonin metabolism and effects—EDN1—glaucoma	2.19e-05	0.0187	CbGpPWpGaD
Formoterol—ADRB1—Endothelin Pathways—EDN1—glaucoma	1.97e-05	0.0168	CbGpPWpGaD
Formoterol—CYP2C19—Tamoxifen metabolism—CYP1B1—glaucoma	1.87e-05	0.0159	CbGpPWpGaD
Formoterol—ADRB1—Melatonin metabolism and effects—APOE—glaucoma	1.78e-05	0.0152	CbGpPWpGaD
Formoterol—CYP2D6—Tamoxifen metabolism—CYP1B1—glaucoma	1.72e-05	0.0146	CbGpPWpGaD
Formoterol—CYP2A6—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—PTGS2—glaucoma	1.71e-05	0.0146	CbGpPWpGaD
Formoterol—CYP2C9—Tamoxifen metabolism—CYP1B1—glaucoma	1.7e-05	0.0145	CbGpPWpGaD
Formoterol—CYP2A6—Fluoropyrimidine Activity—MTHFR—glaucoma	1.51e-05	0.0128	CbGpPWpGaD
Formoterol—CYP2C19—Melatonin metabolism and effects—CYP1B1—glaucoma	1.44e-05	0.0123	CbGpPWpGaD
Formoterol—ADRB1—GPCRs, Class A Rhodopsin-like—MAS1—glaucoma	1.39e-05	0.0119	CbGpPWpGaD
Formoterol—ADRB2—GPCRs, Class A Rhodopsin-like—MAS1—glaucoma	1.36e-05	0.0116	CbGpPWpGaD
Formoterol—CYP2A6—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—VEGFA—glaucoma	1.35e-05	0.0115	CbGpPWpGaD
Formoterol—CYP2D6—Melatonin metabolism and effects—CYP1B1—glaucoma	1.33e-05	0.0113	CbGpPWpGaD
Formoterol—CYP2A6—Cytochrome P450 - arranged by substrate type—CYP1B1—glaucoma	1.32e-05	0.0113	CbGpPWpGaD
Formoterol—CYP2A6—Oxidation by Cytochrome P450—CYP1B1—glaucoma	1.3e-05	0.0111	CbGpPWpGaD
Formoterol—ADRB2—GPCRs, Other—SMO—glaucoma	1.3e-05	0.0111	CbGpPWpGaD
Formoterol—CYP2A6—NRF2 pathway—SLC6A13—glaucoma	1.28e-05	0.0109	CbGpPWpGaD
Formoterol—ADRB1—GPCRs, Class A Rhodopsin-like—OPN4—glaucoma	1.27e-05	0.0108	CbGpPWpGaD
Formoterol—ADRB2—GPCRs, Class A Rhodopsin-like—OPN4—glaucoma	1.24e-05	0.0106	CbGpPWpGaD
Formoterol—ADRB1—Endothelin Pathways—NOS3—glaucoma	1.2e-05	0.0103	CbGpPWpGaD
Formoterol—CYP2C19—Melatonin metabolism and effects—EDN1—glaucoma	1.17e-05	0.00994	CbGpPWpGaD
Formoterol—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCA1—glaucoma	1.16e-05	0.00987	CbGpPWpGaD
Formoterol—ADRB1—GPCRs, Class A Rhodopsin-like—PTGFR—glaucoma	1.15e-05	0.00977	CbGpPWpGaD
Formoterol—ADRB2—GPCRs, Class A Rhodopsin-like—PTGFR—glaucoma	1.12e-05	0.00955	CbGpPWpGaD
Formoterol—ADRB1—Class A/1 (Rhodopsin-like receptors)—OPN4—glaucoma	1.09e-05	0.00929	CbGpPWpGaD
Formoterol—CYP2D6—Melatonin metabolism and effects—EDN1—glaucoma	1.07e-05	0.00914	CbGpPWpGaD
Formoterol—CYP2A6—Phase 1 - Functionalization of compounds—CYP1B1—glaucoma	1.07e-05	0.00913	CbGpPWpGaD
Formoterol—ADRB2—Class A/1 (Rhodopsin-like receptors)—OPN4—glaucoma	1.07e-05	0.00909	CbGpPWpGaD
Formoterol—CYP2A6—NRF2 pathway—TXN—glaucoma	1.05e-05	0.00895	CbGpPWpGaD
Formoterol—ADRB1—Class A/1 (Rhodopsin-like receptors)—PTGFR—glaucoma	9.81e-06	0.00837	CbGpPWpGaD
Formoterol—ADRB2—Class A/1 (Rhodopsin-like receptors)—PTGFR—glaucoma	9.6e-06	0.00819	CbGpPWpGaD
Formoterol—CYP2C19—Melatonin metabolism and effects—APOE—glaucoma	9.48e-06	0.00808	CbGpPWpGaD
Formoterol—CYP2A6—NRF2 pathway—SLC6A1—glaucoma	9.36e-06	0.00798	CbGpPWpGaD
Formoterol—CYP2C19—Arachidonic acid metabolism—CYP1B1—glaucoma	9.32e-06	0.00795	CbGpPWpGaD
Formoterol—CYP2D6—Melatonin metabolism and effects—APOE—glaucoma	8.72e-06	0.00743	CbGpPWpGaD
Formoterol—CYP2C9—Arachidonic acid metabolism—CYP1B1—glaucoma	8.5e-06	0.00725	CbGpPWpGaD
Formoterol—ADRB1—GPCR ligand binding—OPN4—glaucoma	8.3e-06	0.00708	CbGpPWpGaD
Formoterol—ADRB2—GPCR ligand binding—OPN4—glaucoma	8.12e-06	0.00692	CbGpPWpGaD
Formoterol—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP1B1—glaucoma	8.05e-06	0.00687	CbGpPWpGaD
Formoterol—CYP2C19—Oxidation by Cytochrome P450—CYP1B1—glaucoma	7.95e-06	0.00678	CbGpPWpGaD
Formoterol—CYP2A6—NRF2 pathway—TGFB2—glaucoma	7.63e-06	0.0065	CbGpPWpGaD
Formoterol—ADRB1—GPCR ligand binding—PTGFR—glaucoma	7.47e-06	0.00637	CbGpPWpGaD
Formoterol—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP1B1—glaucoma	7.41e-06	0.00632	CbGpPWpGaD
Formoterol—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP1B1—glaucoma	7.34e-06	0.00626	CbGpPWpGaD
Formoterol—CYP2D6—Oxidation by Cytochrome P450—CYP1B1—glaucoma	7.31e-06	0.00623	CbGpPWpGaD
Formoterol—ADRB2—GPCR ligand binding—PTGFR—glaucoma	7.31e-06	0.00623	CbGpPWpGaD
Formoterol—CYP2C9—Oxidation by Cytochrome P450—CYP1B1—glaucoma	7.25e-06	0.00618	CbGpPWpGaD
Formoterol—CYP2A6—Biological oxidations—GSTT1—glaucoma	7.14e-06	0.00609	CbGpPWpGaD
Formoterol—CYP2C19—Phase 1 - Functionalization of compounds—CYP1B1—glaucoma	6.53e-06	0.00557	CbGpPWpGaD
Formoterol—CYP2D6—Phase 1 - Functionalization of compounds—CYP1B1—glaucoma	6.01e-06	0.00512	CbGpPWpGaD
Formoterol—CYP2C9—Phase 1 - Functionalization of compounds—CYP1B1—glaucoma	5.95e-06	0.00508	CbGpPWpGaD
Formoterol—CYP2A6—Fluoropyrimidine Activity—TP53—glaucoma	5.72e-06	0.00488	CbGpPWpGaD
Formoterol—CYP2A6—Biological oxidations—CYP1B1—glaucoma	5.69e-06	0.00485	CbGpPWpGaD
Formoterol—CYP2A6—NRF2 pathway—GSTM1—glaucoma	5.19e-06	0.00442	CbGpPWpGaD
Formoterol—CYP2A6—Metabolism—CA5A—glaucoma	5e-06	0.00427	CbGpPWpGaD
Formoterol—CYP2A6—Metabolism—NARFL—glaucoma	5e-06	0.00427	CbGpPWpGaD
Formoterol—ADRB1—GPCR downstream signaling—OPN4—glaucoma	4.69e-06	0.004	CbGpPWpGaD
Formoterol—ADRB2—GPCR downstream signaling—OPN4—glaucoma	4.59e-06	0.00391	CbGpPWpGaD
Formoterol—CYP2A6—Biological oxidations—GSTM1—glaucoma	4.55e-06	0.00388	CbGpPWpGaD
Formoterol—CYP2C19—Biological oxidations—GSTT1—glaucoma	4.35e-06	0.00371	CbGpPWpGaD
Formoterol—ADRB1—Signaling by GPCR—OPN4—glaucoma	4.26e-06	0.00363	CbGpPWpGaD
Formoterol—ADRB1—GPCR downstream signaling—PTGFR—glaucoma	4.22e-06	0.0036	CbGpPWpGaD
Formoterol—CYP2C19—Arachidonic acid metabolism—PTGS2—glaucoma	4.2e-06	0.00358	CbGpPWpGaD
Formoterol—ADRB2—Signaling by GPCR—OPN4—glaucoma	4.17e-06	0.00355	CbGpPWpGaD
Formoterol—ADRB2—GPCR downstream signaling—PTGFR—glaucoma	4.13e-06	0.00352	CbGpPWpGaD
Formoterol—CYP2D6—Biological oxidations—GSTT1—glaucoma	4e-06	0.00341	CbGpPWpGaD
Formoterol—CYP2C9—Biological oxidations—GSTT1—glaucoma	3.97e-06	0.00338	CbGpPWpGaD
Formoterol—ADRB1—Signaling by GPCR—PTGFR—glaucoma	3.83e-06	0.00327	CbGpPWpGaD
Formoterol—CYP2C9—Arachidonic acid metabolism—PTGS2—glaucoma	3.83e-06	0.00327	CbGpPWpGaD
Formoterol—ADRB1—GPCR ligand binding—SMO—glaucoma	3.77e-06	0.00321	CbGpPWpGaD
Formoterol—ADRB2—Signaling by GPCR—PTGFR—glaucoma	3.75e-06	0.0032	CbGpPWpGaD
Formoterol—ADRB2—GPCR ligand binding—SMO—glaucoma	3.69e-06	0.00314	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—LRP12—glaucoma	3.63e-06	0.0031	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—LRP12—glaucoma	3.55e-06	0.00303	CbGpPWpGaD
Formoterol—CYP2C19—Biological oxidations—CYP1B1—glaucoma	3.47e-06	0.00296	CbGpPWpGaD
Formoterol—CYP2C19—Metapathway biotransformation—CYP1B1—glaucoma	3.42e-06	0.00292	CbGpPWpGaD
Formoterol—ADRB1—Class A/1 (Rhodopsin-like receptors)—EDN1—glaucoma	3.26e-06	0.00278	CbGpPWpGaD
Formoterol—CYP2C19—Metabolism of lipids and lipoproteins—CTSA—glaucoma	3.24e-06	0.00276	CbGpPWpGaD
Formoterol—ADRB2—Class A/1 (Rhodopsin-like receptors)—EDN1—glaucoma	3.19e-06	0.00272	CbGpPWpGaD
Formoterol—CYP2D6—Biological oxidations—CYP1B1—glaucoma	3.19e-06	0.00272	CbGpPWpGaD
Formoterol—CYP2C9—Biological oxidations—CYP1B1—glaucoma	3.16e-06	0.0027	CbGpPWpGaD
Formoterol—CYP2D6—Metapathway biotransformation—CYP1B1—glaucoma	3.15e-06	0.00268	CbGpPWpGaD
Formoterol—CYP2C9—Metapathway biotransformation—CYP1B1—glaucoma	3.12e-06	0.00266	CbGpPWpGaD
Formoterol—CYP2C19—Metabolism—NARFL—glaucoma	3.05e-06	0.0026	CbGpPWpGaD
Formoterol—CYP2C19—Metabolism—CA5A—glaucoma	3.05e-06	0.0026	CbGpPWpGaD
Formoterol—CYP2C9—Metabolism of lipids and lipoproteins—CTSA—glaucoma	2.95e-06	0.00252	CbGpPWpGaD
Formoterol—ADRB1—Class A/1 (Rhodopsin-like receptors)—C3—glaucoma	2.85e-06	0.00243	CbGpPWpGaD
Formoterol—CYP2D6—Metabolism—CA5A—glaucoma	2.81e-06	0.00239	CbGpPWpGaD
Formoterol—CYP2D6—Metabolism—NARFL—glaucoma	2.81e-06	0.00239	CbGpPWpGaD
Formoterol—ADRB2—Class A/1 (Rhodopsin-like receptors)—C3—glaucoma	2.79e-06	0.00238	CbGpPWpGaD
Formoterol—CYP2C9—Metabolism—CA5A—glaucoma	2.78e-06	0.00237	CbGpPWpGaD
Formoterol—CYP2C9—Metabolism—NARFL—glaucoma	2.78e-06	0.00237	CbGpPWpGaD
Formoterol—CYP2C19—Biological oxidations—GSTM1—glaucoma	2.77e-06	0.00236	CbGpPWpGaD
Formoterol—CYP2C19—Metapathway biotransformation—GSTM1—glaucoma	2.73e-06	0.00233	CbGpPWpGaD
Formoterol—CYP2D6—Biological oxidations—GSTM1—glaucoma	2.55e-06	0.00217	CbGpPWpGaD
Formoterol—CYP2C9—Biological oxidations—GSTM1—glaucoma	2.53e-06	0.00216	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—OPN4—glaucoma	2.52e-06	0.00215	CbGpPWpGaD
Formoterol—CYP2D6—Metapathway biotransformation—GSTM1—glaucoma	2.52e-06	0.00214	CbGpPWpGaD
Formoterol—CYP2C9—Metapathway biotransformation—GSTM1—glaucoma	2.49e-06	0.00213	CbGpPWpGaD
Formoterol—ADRB1—GPCR ligand binding—EDN1—glaucoma	2.48e-06	0.00212	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—OPN4—glaucoma	2.46e-06	0.0021	CbGpPWpGaD
Formoterol—CYP2A6—Metabolism—CA1—glaucoma	2.44e-06	0.00208	CbGpPWpGaD
Formoterol—ADRB2—GPCR ligand binding—EDN1—glaucoma	2.43e-06	0.00207	CbGpPWpGaD
Formoterol—CYP2A6—Metabolism—CTSA—glaucoma	2.37e-06	0.00202	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—HEYL—glaucoma	2.34e-06	0.00199	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—HEYL—glaucoma	2.29e-06	0.00195	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—PTGFR—glaucoma	2.27e-06	0.00193	CbGpPWpGaD
Formoterol—CYP2A6—Metabolism—CA2—glaucoma	2.24e-06	0.00191	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—PTGFR—glaucoma	2.22e-06	0.00189	CbGpPWpGaD
Formoterol—ADRB1—GPCR ligand binding—C3—glaucoma	2.17e-06	0.00185	CbGpPWpGaD
Formoterol—ADRB2—GPCR ligand binding—C3—glaucoma	2.12e-06	0.00181	CbGpPWpGaD
Formoterol—ADRB1—Signaling by GPCR—SMO—glaucoma	1.93e-06	0.00165	CbGpPWpGaD
Formoterol—ADRB2—Signaling by GPCR—SMO—glaucoma	1.89e-06	0.00161	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—RPTOR—glaucoma	1.77e-06	0.00151	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—RPTOR—glaucoma	1.73e-06	0.00148	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—NCK2—glaucoma	1.72e-06	0.00146	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—NCK2—glaucoma	1.68e-06	0.00143	CbGpPWpGaD
Formoterol—CYP2A6—Metabolism—TXN—glaucoma	1.57e-06	0.00134	CbGpPWpGaD
Formoterol—CYP2C19—Metabolism—CA1—glaucoma	1.49e-06	0.00127	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—HDAC9—glaucoma	1.46e-06	0.00124	CbGpPWpGaD
Formoterol—CYP2C19—Metabolism—CTSA—glaucoma	1.44e-06	0.00123	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—HDAC9—glaucoma	1.43e-06	0.00122	CbGpPWpGaD
Formoterol—ADRB1—GPCR downstream signaling—EDN1—glaucoma	1.4e-06	0.0012	CbGpPWpGaD
Formoterol—ADRB2—GPCR downstream signaling—EDN1—glaucoma	1.37e-06	0.00117	CbGpPWpGaD
Formoterol—CYP2D6—Metabolism—CA1—glaucoma	1.37e-06	0.00117	CbGpPWpGaD
Formoterol—CYP2C19—Metabolism—CA2—glaucoma	1.36e-06	0.00116	CbGpPWpGaD
Formoterol—CYP2C9—Metabolism—CA1—glaucoma	1.36e-06	0.00116	CbGpPWpGaD
Formoterol—CYP2C19—Metabolism of lipids and lipoproteins—CYP1B1—glaucoma	1.33e-06	0.00114	CbGpPWpGaD
Formoterol—CYP2C19—Metabolism of lipids and lipoproteins—ABCA1—glaucoma	1.33e-06	0.00114	CbGpPWpGaD
Formoterol—CYP2D6—Metabolism—CTSA—glaucoma	1.33e-06	0.00113	CbGpPWpGaD
Formoterol—CYP2C9—Metabolism—CTSA—glaucoma	1.32e-06	0.00112	CbGpPWpGaD
Formoterol—ADRB1—Signaling by GPCR—EDN1—glaucoma	1.27e-06	0.00109	CbGpPWpGaD
Formoterol—CYP2D6—Metabolism—CA2—glaucoma	1.25e-06	0.00107	CbGpPWpGaD
Formoterol—ADRB2—Signaling by GPCR—EDN1—glaucoma	1.25e-06	0.00106	CbGpPWpGaD
Formoterol—CYP2C9—Metabolism—CA2—glaucoma	1.24e-06	0.00106	CbGpPWpGaD
Formoterol—ADRB1—GPCR downstream signaling—C3—glaucoma	1.23e-06	0.00105	CbGpPWpGaD
Formoterol—CYP2A6—Metabolism—GSTT1—glaucoma	1.22e-06	0.00104	CbGpPWpGaD
Formoterol—CYP2C9—Metabolism of lipids and lipoproteins—CYP1B1—glaucoma	1.21e-06	0.00104	CbGpPWpGaD
Formoterol—CYP2C9—Metabolism of lipids and lipoproteins—ABCA1—glaucoma	1.21e-06	0.00104	CbGpPWpGaD
Formoterol—ADRB2—GPCR downstream signaling—C3—glaucoma	1.2e-06	0.00102	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—SMO—glaucoma	1.14e-06	0.000974	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—SMO—glaucoma	1.12e-06	0.000953	CbGpPWpGaD
Formoterol—ADRB1—Signaling by GPCR—C3—glaucoma	1.11e-06	0.00095	CbGpPWpGaD
Formoterol—ADRB2—Signaling by GPCR—C3—glaucoma	1.09e-06	0.000929	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—NTRK2—glaucoma	1.04e-06	0.000891	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—NTRK2—glaucoma	1.02e-06	0.000872	CbGpPWpGaD
Formoterol—CYP2A6—Metabolism—CYP1B1—glaucoma	9.73e-07	0.00083	CbGpPWpGaD
Formoterol—CYP2A6—Metabolism—ABCA1—glaucoma	9.73e-07	0.00083	CbGpPWpGaD
Formoterol—CYP2C19—Metabolism—TXN—glaucoma	9.6e-07	0.000819	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—NGFR—glaucoma	8.96e-07	0.000764	CbGpPWpGaD
Formoterol—CYP2D6—Metabolism—TXN—glaucoma	8.83e-07	0.000753	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—NGFR—glaucoma	8.77e-07	0.000748	CbGpPWpGaD
Formoterol—CYP2C19—Metabolism of lipids and lipoproteins—APOE—glaucoma	8.76e-07	0.000747	CbGpPWpGaD
Formoterol—CYP2C9—Metabolism—TXN—glaucoma	8.75e-07	0.000747	CbGpPWpGaD
Formoterol—CYP2C19—Metabolism of lipids and lipoproteins—CAV1—glaucoma	8.68e-07	0.00074	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—NTRK1—glaucoma	8.52e-07	0.000726	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—NTRK1—glaucoma	8.33e-07	0.00071	CbGpPWpGaD
Formoterol—CYP2C9—Metabolism of lipids and lipoproteins—APOE—glaucoma	7.99e-07	0.000681	CbGpPWpGaD
Formoterol—CYP2C9—Metabolism of lipids and lipoproteins—CAV1—glaucoma	7.91e-07	0.000675	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—CDKN2B—glaucoma	7.85e-07	0.000669	CbGpPWpGaD
Formoterol—CYP2A6—Metabolism—GSTM1—glaucoma	7.78e-07	0.000663	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—CDKN2B—glaucoma	7.68e-07	0.000655	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—EDN1—glaucoma	7.53e-07	0.000642	CbGpPWpGaD
Formoterol—CYP2C19—Metabolism—GSTT1—glaucoma	7.44e-07	0.000635	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—EDN1—glaucoma	7.37e-07	0.000628	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—NGF—glaucoma	6.92e-07	0.00059	CbGpPWpGaD
Formoterol—CYP2A6—Metabolism—MTHFR—glaucoma	6.87e-07	0.000586	CbGpPWpGaD
Formoterol—CYP2D6—Metabolism—GSTT1—glaucoma	6.85e-07	0.000584	CbGpPWpGaD
Formoterol—CYP2C9—Metabolism—GSTT1—glaucoma	6.79e-07	0.000579	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—NGF—glaucoma	6.77e-07	0.000577	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—C3—glaucoma	6.58e-07	0.000561	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—C3—glaucoma	6.44e-07	0.000549	CbGpPWpGaD
Formoterol—CYP2A6—Metabolism—APOE—glaucoma	6.4e-07	0.000546	CbGpPWpGaD
Formoterol—CYP2A6—Metabolism—CAV1—glaucoma	6.34e-07	0.000541	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—APOE—glaucoma	6.13e-07	0.000522	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—CAV1—glaucoma	6.07e-07	0.000518	CbGpPWpGaD
Formoterol—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—glaucoma	6e-07	0.000512	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—APOE—glaucoma	5.99e-07	0.000511	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—CAV1—glaucoma	5.94e-07	0.000506	CbGpPWpGaD
Formoterol—CYP2C19—Metabolism—ABCA1—glaucoma	5.93e-07	0.000506	CbGpPWpGaD
Formoterol—CYP2C19—Metabolism—CYP1B1—glaucoma	5.93e-07	0.000506	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—FN1—glaucoma	5.78e-07	0.000493	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—BAD—glaucoma	5.71e-07	0.000487	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—FN1—glaucoma	5.65e-07	0.000482	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—BAD—glaucoma	5.58e-07	0.000476	CbGpPWpGaD
Formoterol—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—glaucoma	5.47e-07	0.000467	CbGpPWpGaD
Formoterol—CYP2D6—Metabolism—CYP1B1—glaucoma	5.46e-07	0.000465	CbGpPWpGaD
Formoterol—CYP2D6—Metabolism—ABCA1—glaucoma	5.46e-07	0.000465	CbGpPWpGaD
Formoterol—CYP2C9—Metabolism—ABCA1—glaucoma	5.41e-07	0.000461	CbGpPWpGaD
Formoterol—CYP2C9—Metabolism—CYP1B1—glaucoma	5.41e-07	0.000461	CbGpPWpGaD
Formoterol—CYP2A6—Metabolism—NOS3—glaucoma	4.79e-07	0.000409	CbGpPWpGaD
Formoterol—CYP2C19—Metabolism—GSTM1—glaucoma	4.74e-07	0.000404	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—NOS3—glaucoma	4.59e-07	0.000391	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—NOS3—glaucoma	4.49e-07	0.000383	CbGpPWpGaD
Formoterol—CYP2A6—Metabolism—PTGS2—glaucoma	4.38e-07	0.000374	CbGpPWpGaD
Formoterol—CYP2D6—Metabolism—GSTM1—glaucoma	4.36e-07	0.000372	CbGpPWpGaD
Formoterol—CYP2C9—Metabolism—GSTM1—glaucoma	4.32e-07	0.000369	CbGpPWpGaD
Formoterol—CYP2C19—Metabolism—MTHFR—glaucoma	4.19e-07	0.000357	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—CDKN1B—glaucoma	3.98e-07	0.000339	CbGpPWpGaD
Formoterol—CYP2C19—Metabolism—APOE—glaucoma	3.9e-07	0.000333	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—CDKN1B—glaucoma	3.89e-07	0.000332	CbGpPWpGaD
Formoterol—CYP2C19—Metabolism—CAV1—glaucoma	3.87e-07	0.00033	CbGpPWpGaD
Formoterol—CYP2D6—Metabolism—MTHFR—glaucoma	3.85e-07	0.000329	CbGpPWpGaD
Formoterol—CYP2C9—Metabolism—MTHFR—glaucoma	3.82e-07	0.000326	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—MMP9—glaucoma	3.68e-07	0.000314	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—MMP9—glaucoma	3.6e-07	0.000307	CbGpPWpGaD
Formoterol—CYP2D6—Metabolism—APOE—glaucoma	3.59e-07	0.000306	CbGpPWpGaD
Formoterol—CYP2C9—Metabolism—APOE—glaucoma	3.56e-07	0.000303	CbGpPWpGaD
Formoterol—CYP2D6—Metabolism—CAV1—glaucoma	3.56e-07	0.000303	CbGpPWpGaD
Formoterol—CYP2C9—Metabolism—CAV1—glaucoma	3.52e-07	0.000301	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—VEGFA—glaucoma	3.31e-07	0.000282	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—VEGFA—glaucoma	3.23e-07	0.000276	CbGpPWpGaD
Formoterol—CYP2C19—Metabolism—NOS3—glaucoma	2.92e-07	0.000249	CbGpPWpGaD
Formoterol—CYP2D6—Metabolism—NOS3—glaucoma	2.69e-07	0.000229	CbGpPWpGaD
Formoterol—CYP2C19—Metabolism—PTGS2—glaucoma	2.67e-07	0.000228	CbGpPWpGaD
Formoterol—CYP2C9—Metabolism—NOS3—glaucoma	2.67e-07	0.000227	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—TP53—glaucoma	2.5e-07	0.000213	CbGpPWpGaD
Formoterol—CYP2D6—Metabolism—PTGS2—glaucoma	2.46e-07	0.00021	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—TP53—glaucoma	2.44e-07	0.000208	CbGpPWpGaD
Formoterol—CYP2C9—Metabolism—PTGS2—glaucoma	2.44e-07	0.000208	CbGpPWpGaD
